Xylem Inc. (NYSE:XYL)‘s stock had its “hold” rating reaffirmed by equities researchers at Stifel Nicolaus in a research report issued to clients and investors on Friday. They currently have a $63.00 price target on the industrial products company’s stock. Stifel Nicolaus’ target price would indicate a potential downside of 2.90% from the stock’s previous close.
Other equities analysts have also recently issued research reports about the company. Cowen and Company restated an “outperform” rating and set a $70.00 target price (up previously from $60.00) on shares of Xylem in a report on Wednesday, August 9th. Royal Bank Of Canada lifted their price objective on Xylem from $58.00 to $64.00 and gave the company an “outperform” rating in a report on Wednesday, August 2nd. Oppenheimer Holdings, Inc. lifted their price objective on Xylem from $60.00 to $66.00 and gave the company an “outperform” rating in a report on Wednesday, August 2nd. Boenning Scattergood reiterated an “outperform” rating on shares of Xylem in a report on Tuesday, September 5th. Finally, Robert W. Baird reiterated a “hold” rating and set a $67.00 price objective on shares of Xylem in a report on Wednesday, October 4th. Six investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Xylem has a consensus rating of “Buy” and a consensus price target of $61.92.
Shares of Xylem (NYSE XYL) opened at 64.71 on Friday. The firm’s 50-day moving average price is $63.30 and its 200 day moving average price is $56.40. The firm has a market cap of $11.62 billion, a P/E ratio of 41.78 and a beta of 1.17. Xylem has a 12-month low of $45.60 and a 12-month high of $65.42.
Xylem (NYSE:XYL) last issued its earnings results on Tuesday, August 1st. The industrial products company reported $0.59 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.02. Xylem had a return on equity of 17.26% and a net margin of 6.58%. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter last year, the business earned $0.48 earnings per share. The company’s revenue was up 24.9% compared to the same quarter last year. On average, equities analysts expect that Xylem will post $2.38 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Xylem Inc. (XYL) Rating Reiterated by Stifel Nicolaus” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another website, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/10/15/xylem-inc-xyl-rating-reiterated-by-stifel-nicolaus.html.
In related news, insider Kenneth Napolitano sold 9,052 shares of the business’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $60.16, for a total value of $544,568.32. Following the completion of the sale, the insider now directly owns 35,303 shares in the company, valued at approximately $2,123,828.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.75% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Harfst & Associates Inc. lifted its position in shares of Xylem by 26.1% during the 2nd quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock valued at $134,000 after acquiring an additional 503 shares during the period. CENTRAL TRUST Co lifted its position in shares of Xylem by 160.3% during the 2nd quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock valued at $146,000 after acquiring an additional 1,635 shares during the period. FNY Partners Fund LP bought a new stake in shares of Xylem during the 1st quarter valued at $151,000. Tower Research Capital LLC TRC bought a new stake in shares of Xylem during the 2nd quarter valued at $168,000. Finally, Federated Investors Inc. PA lifted its position in shares of Xylem by 5.8% during the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock valued at $182,000 after acquiring an additional 181 shares during the period. Institutional investors and hedge funds own 86.40% of the company’s stock.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.